What is the most significant risk for a pregnant woman diagnosed with syphilis if left untreated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Congenital Syphilis is the Most Significant Risk

If left untreated, a pregnant woman with syphilis is most at risk for congenital syphilis, which results in stillbirth in up to 40% of cases, with additional risks of neonatal death, severe fetal infection, and permanent sequelae in surviving infants. 1, 2

Understanding the Magnitude of Risk

The consequences of untreated maternal syphilis are devastating and directly impact fetal morbidity and mortality:

  • Stillbirth occurs in approximately 40% of pregnancies with untreated maternal syphilis, making it the most catastrophic outcome 2
  • Among pregnancies that continue beyond 20 weeks gestation with untreated syphilis, up to 40% of fetuses are either stillborn or die from infection during infancy 2
  • Congenital syphilis develops when maternal infection transmits to the fetus through the placenta, and this can occur at any stage of maternal disease and in any trimester 3

Specific Fetal and Neonatal Complications

Beyond stillbirth, untreated maternal syphilis causes severe fetal pathology:

  • Sonographic findings of fetal syphilis include hepatomegaly, placentomegaly, ascites, hydrops fetalis, fetal anemia (detected by elevated middle cerebral artery peak systolic velocity), and thickened placenta 1, 3
  • Neonatal manifestations include nonimmune hydrops, jaundice, hepatosplenomegaly, rhinitis, skin rash, and pseudoparalysis of extremities 1
  • Pregnancies with ultrasound abnormalities carry higher risk for fetal treatment failure even when maternal treatment is administered 1, 3

Stage-Specific Maternal Risk

The risk of fetal treatment failure varies by maternal disease stage:

  • Secondary syphilis carries the highest risk of fetal treatment failure compared to other stages, with a success rate of only 94.7% (71 of 75 cases) versus 98.2% overall 4
  • Two of six fetal treatment failures in one study resulted in preterm stillborns, both occurring in mothers with secondary syphilis 4

Critical Treatment Window

The effectiveness of preventing congenital syphilis depends entirely on timing:

  • Maternal treatment with penicillin is 98% effective at preventing congenital syphilis when administered appropriately during pregnancy and at least 28 days before delivery 5, 6
  • Inadequate maternal treatment is the strongest predictor of congenital syphilis, with an adjusted odds ratio of 86.1 (95% CI: 15.9-466.5) 6
  • Screening in the third trimester (AOR 8.4,95% CI: 2.9-24.6) or fewer than 28 days before delivery (AOR 8.1,95% CI: 1.4-47.8) significantly increases risk of congenital syphilis compared to first or second trimester screening 6

Additional Maternal Complications

While congenital syphilis is the primary concern, untreated maternal syphilis also poses direct maternal risks:

  • Placental inflammation from congenital infection may increase the risk of perinatal HIV transmission in co-infected women 1
  • Premature labor and fetal distress can occur if treatment precipitates the Jarisch-Herxheimer reaction, particularly when treatment occurs in the second half of pregnancy 1

Common Pitfall to Avoid

Never delay treatment due to concerns about Jarisch-Herxheimer reaction causing stillbirth—while stillbirth is a rare complication of treatment itself, untreated syphilis causes far greater fetal harm with stillbirth rates up to 40% 1, 7, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Syphilis: A Review.

JAMA, 2025

Research

Syphilis during pregnancy: a preventable threat to maternal-fetal health.

American journal of obstetrics and gynecology, 2017

Research

Efficacy of treatment for syphilis in pregnancy.

Obstetrics and gynecology, 1999

Research

Increase in incidence of congenital syphilis - United States, 2012-2014.

MMWR. Morbidity and mortality weekly report, 2015

Research

Outcomes of infectious syphilis in pregnant patients and maternal factors associated with congenital syphilis diagnosis, Alberta, 2017-2020.

Canada communicable disease report = Releve des maladies transmissibles au Canada, 2022

Guideline

Syphilis Treatment in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.